Victor Riitho
@Riitho
Followers
474
Following
2K
Media
6
Statuses
678
AI chatbots are sycophants — researchers say it’s harming science
nature.com
Nature - Nature asked researchers who use artificial intelligence how its propensity for people-pleasing affects their work — and what they are doing to mitigate it.
0
0
0
‘Of all the moments for science to slow down, this is not it.’ - An HIV vaccine academy showcases the scientific talent of African researchers but is tempered by funding worries
iavi.org
After USAID funding cuts, African institutions are finding ways to maintain HIV vaccine and prevention research in sub-Saharan Africa.
0
0
0
We were delighted to host a delegation from @IAVI at KAVI-Institute of Clinical Research 🤝 A long history of collaboration in vaccine trials as we plan new joint grants & community engagement ahead of #WorldAIDSDay 2025. #KeepScienceAlive #VaccineResearch #Partnerships
0
1
3
Six journal rejections and a major rethink: why I’m happy to admit to my research failures, and you should too
nature.com
Nature - Outlining the trial-and-error processes that are involved in every research project could help others to become more efficient and paint a more honest picture of life as a researcher.
0
0
0
Spent 4 days in Northern Kenya and hiked, • Mount Ng'iro (2,848m) - The Highest Mountain in Samburu County. • Mount Kulal (2,285m) - The Highest Mountain in Marsabit County.
9
55
326
Following #WorldRabiesDay (28th September), the conversation continues... Dr Pauline Gitonga, Senior Research Fellow at #CEMA provides key insights into rabies. 👉 Watch the full discussion here: https://t.co/pwlw0Yae5U
#rabiesprevention #rabiesawareness #health
Why washing a dog bite wound with water and soap for 15 minutes could save you from rabies! Dr Pauline Gitonga explains first aid procedures and why vaccinating dogs is crucial in preventing human cases. #FixingTheNationNTV
@nationfmke @ericlatiff @officialjmbugua
0
5
6
📢 Save the Date! Join us for the next #CEMASeminarSeries on October 8, 2025, at 12PM EAT. Together with @GLIDE_AE our speakers will discuss: “From Data to Action: Modelling for Better Decision-Making in Disease Elimination.” Register here: https://t.co/R5fvVpG2O8
0
11
15
Unraveling the arc of vaccine progress | Science
science.org
The philosopher Thomas Hobbes famously described life in 1651 as “nasty, brutish, and short.” He was undeniably correct, with estimates of average life expectancy in the UK at the time ranging from...
0
0
1
Malaria resurgence in Africa: confronting the challenges - The Lancet Infectious Diseases
thelancet.com
WHO's 2024 World Malaria Report highlights that the global burden of malaria remains concentrated in Africa, accounting for 95% of the 263 million malaria cases and deaths worldwide.1 Children...
0
0
0
Strengthening vaccine capacity building on the African continent
nature.com
Nature Communications - The African Union (AU) has set an ambitious goal to strengthen primary health care systems on the African continent and achieve universal health coverage for all African...
0
0
1
Beyond the Bonus: ‘Why Kenya’s Ad-Hoc Rewards Should Signal Structural Reform’ by Louis Kimanzi https://t.co/CDEYcu6iCd
medium.com
Kenya must not let this moment be just another euphoric flare that burns out after the final whistle. Let it be the spark that ignites…
0
0
0
How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
nature.com
npj Vaccines - How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
1
0
0
Evolving rare B cell lineages for an effective HIV vaccine | Science
science.org
Clinical trials show that strategies to elicit the production of broadly neutralizing antibodies have a promising start
0
0
0
R&D experts to create playbooks that map immune markers in deadly diseases
cepi.net
CEPI to support PATH with US$8 million to create playbooks that map all available R&D into specific immune markers that indicate protection against
0
0
0
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection https://t.co/IzZfKQlWJz via @Gilead
gilead.com
Yeztugo® (Lenacapavir) Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection
0
0
0
Read this #preprint on @researchsquare: Enteropathogen detection and early mortality among people with advanced HIV disease in sub-Saharan Africa
researchsquare.com
One-third of people with HIV in sub-Saharan Africa initiate treatment with advanced HIV disease, with high associated mortality. Whether enteropathogens and intestinal inflammation contribute to...
0
0
0